Clinical trial Recruiting at 1 site Interventional Ages 18 to 89

Using AI to improve IVF and ART outcomes

Official title: The Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes

Run by Weill Medical College of Cornell University · NCT04255615 · Data updated 2026-11-12

This study is testing whether using artificial intelligence can help doctors better predict the success of IVF treatments by analyzing patient data and ultrasound images.

Quick facts

Study typeInterventional
Ages18 Years to 89 Years
SexAll
Enrollment4000 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedFebruary 12, 2020
Main results expectedJanuary 31, 2029
Study endsSeptember 30, 2029
Registry record updatedDecember 24, 2025
Trial IDNCT04255615 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals undergoing ovarian stimulation for IVF or assisted reproductive techniques, along with their healthy male partners.

Probably not a fit

Patients who are not undergoing ART cycles or those without male partners may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to utilize artificial intelligence to analyze clinical data and predict the outcomes of assisted reproductive techniques, specifically in vitro fertilization (IVF). By employing machine learning techniques, the study will assess baseline ovarian reserve through 3D transvaginal ultrasound imaging to objectively identify antral follicle counts. The goal is to develop an automated tool that reduces physician bias and enhances the accuracy of clinical assessments. Data will be collected from participants undergoing ovarian stimulation, including medical history and treatment outcomes.

Why it matters

Potential benefit: If successful, this approach could lead to improved IVF success rates and more personalized treatment plans for patients experiencing infertility.

How similar studies have gone: Other studies have shown promise in using AI for clinical assessments, suggesting potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients undergoing ovarian stimulation (including OI and IVF cycles)
* Treatment for fresh embryo transfer and cryopreservation of oocytes or embryos upfront
* Healthy male partners of the female subjects who agree to be part of the study.

Exclusion Criteria:

* None

Where it's running

  • Weill Cornell Medicine
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Nikica Zaninovic, PHD — Weill Medical College of Cornell University
  • Study coordinator: Nikica Zaninovic, PhD
  • Email: nizanin@med.cornell.edu
  • Phone: 646-962-2764

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.